Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Closed
Phase 1
This trial is looking at tocilizumab before obinutuzumab with chlorambucil for people who haven’t had treatment for B cell chronic lymphocytic leukaemia (CLL).
Recruitment start: 1 January 2016
Recruitment end: 6 February 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor John Gribben
Experimental Cancer Medicine Centre (ECMC)
F.Hoffmann-La Roche Ltd (Roche)
Last reviewed: 06 Feb 2018
CRUK internal database number: 14051
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
